Home›Stock Screener›Metropolis Healthcare›Quarterly Results

Metropolis Healthcare Quarterly Results

Latest Quarter Net Profit
₹76 Cr
QSept 2026
Quarterly Results

Metropolis Healthcare quarterly results. In Sept 2026, Metropolis Healthcare (METROPOLIS) reported revenue ₹505 Cr and net profit ₹76 Cr — revenue +17.4% YoY. View METROPOLIS yearly price range for the annual high/low range and current price position.

METROPOLIS Quarterly Results — Revenue, Profit & EPS Highlights

Metropolis Healthcare latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. Also explore METROPOLIS share price data to track price trends across different timeframes.

  • Revenue of ₹505 Cr in Sept 2026 (+16.6% vs Mar 2026, +17.4% vs Sept 2025)
  • Net Profit of ₹76 Cr in Sept 2026 (+49.0% vs Mar 2026, +43.4% vs Sept 2025)
  • EBITDA of ₹143 Cr in Sept 2026 (+23.3% vs Mar 2026)
  • Operating Margin of 27.0% in Sept 2026 (+2.0pp vs Mar 2026)
  • Earnings Per Share of ₹3.64 in Sept 2026 (+48.0% vs Mar 2026)

Metropolis Healthcare Quarterly Results — Revenue, EBITDA, Net Profit & EPS

METROPOLIS quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric Sept 2026 Mar 2026 Jun 2026 Sept 2025 Mar 2025 QoQ YoY
Revenue (₹ Cr) 505 433 455 430 352 16.6% 17.4%
Net Profit (₹ Cr) 76 51 57 53 29 - -
EBITDA (₹ Cr) 143 116 116 109 69 - -
EPS (₹) 3.64 2.46 2.73 10.17 5.69 - -
Operating Margin (%) 27.0% 25.0% 25.0% 25.0% 18.0% - -

METROPOLIS Share Price Trend — 1-Year Movement Across Quarterly Results

Metropolis Healthcare 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. For annual financials, live price and key ratios, visit Metropolis Healthcare stock price NSE.

Profitability Ratios

Profit Margin 15.0%
EBITDA Margin 28.3%
Operating Margin 27.0%
ROE (Annual) 19.9%

Balance Sheet Highlights

Total Assets ₹2,138 Cr
Total Equity ₹1,525 Cr
Current Assets ₹ Cr
Current Liabilities ₹280 Cr

Cash Flow Analysis

Operating Cash Flow ₹351 Cr
Investing Cash Flow ₹-220 Cr
Financing Cash Flow ₹-115 Cr
Net Cash Flow ₹15 Cr

Current Market Data

Current Price ₹558.70
Exchange NSE
Last Updated Nov 19, 2026

METROPOLIS vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap

Metropolis Healthcare latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Sept 2026
₹451,074.97 Cr 1900.0 16,617 1,995 +10.6% - 12.0% 228.9
Divis Laboratories
Sept 2026
₹294,139.19 Cr 11178.0 3,770 1,127 +26.3% - 29.9% 263.1
Torrent Pharmaceuti…
Mar 2026
₹188,719.51 Cr 4611.0 4,111 364 +27.7% +42.2% 8.9% 400.6
Apollo Hospitals
Sept 2026
₹126,832.45 Cr 8738.0 7,673 660 +15.2% - 8.6% 199.4
Laurus Labs
Sept 2026
₹125,946.78 Cr 2306.0 2,219 436 +21.7% - 19.6% 282.3
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data

QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores